Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kawasan Industri Jababeka Tbk. (KIJA) vs Merck Tbk. (MERK) Price & Performance

Kawasan Industri Jababeka Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Kawasan Industri Jababeka Tbk. vs Merck Tbk. — how do they compare? Kawasan Industri Jababeka Tbk. trades at Rp197 (market cap 3.96T, 426.54M 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Kawasan Industri Jababeka Tbk. is far larger — about 2.3× Merck Tbk.'s market cap, and Kawasan Industri Jababeka Tbk. is more actively traded (426.54M versus 63K). Which is the better fit depends on your goals.

KIJAMERK
Market Cap
3.96T1.76T
Volume
426.54M63K
Lot
4.27M630
Turnover
83.21B243.97M
Average Price
195.093,872.46
Value
83.21B243.97M
Indicative Equilibrium Price
1973,900
Indicative Equilibrium Volume
118.64K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KIJA
View details
MERK
View details

About Kawasan Industri Jababeka Tbk.

PT Kawasan Industri Jababeka Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No.6 year 1968 which was amended by Law No.12 year 1970, based on notarial deed No.18 of Maria Kristiana Soeharyo, S.H., dated January 12, 1989. The Company started its commercial operations in 1990. The Companys shares are listed on JSX and SSX.

Read more on KIJA

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK